Publication | Open Access

Simvastatin potentiates the anti-hepatitis B virus activity of FDA-approved nucleoside analogue inhibitors in vitro

Viral HepatitisPharmacologyAntiviral Drug DevelopmentHepatitisAntiviral TherapyPharmacotherapyAntiviral DrugMedicineAntiviral CompoundDrug Discovery